CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study
Pharmaceuticals · 22.05.2026 · 19 (6) · 812
DOI: 10.3390/ph19060812 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 22.05.2026. Verfasst von Alten Oskay und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Pamukkale University Faculty of Medicine, 20070 Denizli, Türkiye. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Personalized Innovative Medicine Competence Center-2 (PERIMED-2).
Abstract (Originalsprache)
Background/Objectives: Cytochrome P450 enzymes (CYP2D6, CYP2C19, CYP3A4) play a key role in interindividual variability in cardiovascular drug metabolism. This study aimed to describe metabolizer phenotype distributions in a Turkish emergency cardiac cohort and across diagnostic categories.
Methods
This retrospective descriptive pharmacogenomic study included 250 patients. Genotyping was performed using TaqMan assays for CYP2D6 (*2, *4, *10, *41), CYP2C19 (*2, *17), and CYP3A4 (*22, *1B). Phenotypes were assigned according to CPIC guidelines. CYP2D6 copy-number variation was not assessed.
Results
Non-normal metabolizer phenotypes were observed in 55.6% (CYP2D6), 84.4% (CYP2C19), and 30.4% (CYP3A4) of patients. For CYP2D6, normal (44.4%) and intermediate (42.0%) metabolizers predominated. For CYP2C19, intermediate metabolizers were most frequent (36.0%), followed by normal (22.8%), rapid (17.2%), poor (14.8%), and ultra-rapid metabolizers (9.2%). CYP3A4 showed predominantly normal activity (69.6%). Phenotype distributions varied across diagnoses without clear clustering.
Conclusions
A high prevalence of CYP2D6 and CYP2C19 variability with predicted functional relevance based on CPIC was observed, whereas CYP3A4 activity was more stable. These findings provide descriptive pharmacogenomic data to support future genotype-guided cardiovascular therapy studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, Pamukkale University Faculty of Medicine, 20070 Denizli, Türkiye.
- Department of Cardiology, Denizli State Hospital, 20000 Denizli, Türkiye.
- Department of Biophysics, Pamukkale University Faculty of Medicine, 20070 Denizli, Türkiye.
- Department of Cardiology, Pamukkale University Faculty of Medicine, 20070 Denizli, Türkiye.
- Department of Medical Microbiology and Immunology "Prof. Dr. Elissay Yanev", Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
- Research Institute, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
ORCID-Profile: Alten Oskay, Veli Kaan Aydın, Murat Seyit, İbrahim Türkçüer, Gergana Lengerova, Martina Bozhkova, Steliyan Petrov, Aylin Köseler
Förderung
- Personalized Innovative Medicine Competence Center-2 (PERIMED-2)
Zitieren
APA
Oskay, A., Oskay, T., Aydın, V. K., Eser, Ö., Seyit, M., Tekin, I., Özen, M., Yılmaz, A., Türkçüer, İ., Lengerova, G., Bozhkova, M., Petrov, S., & Köseler, A. (2026). CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study. Pharmaceuticals, 19(6), 812. https://doi.org/10.3390/ph19060812
Vancouver
Oskay A, Oskay T, Aydın VK, Eser Ö, Seyit M, Tekin I, et al. CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study. Pharmaceuticals. 2026;19(6):812. doi:10.3390/ph19060812
BibTeX
@article{Oskay2026,
author = {Oskay, Alten and Oskay, Tülay and Aydın, Veli Kaan and Eser, Özer and Seyit, Murat and Tekin, Işık and Özen, Mert and Yılmaz, Atakan and Türkçüer, İbrahim and Lengerova, Gergana and Bozhkova, Martina and Petrov, Steliyan and Köseler, Aylin},
title = {CYP450 Metabolizer Phenotypes in a Turkish Emergency Cardiac Patient Cohort: A Descriptive Pharmacogenomic Study},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {812},
doi = {10.3390/ph19060812}
}
EUVIMED